Consciousness Field Project: Intention Host Device-mediated Distant Intentionality
NCT ID: NCT03403764
Last Updated: 2020-01-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
230 participants
INTERVENTIONAL
2016-04-30
2019-11-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Commercially Available Technology in Augmenting Sleep and Well-being
NCT05118191
Awareness and Self-Compassion Enhancing Narcolepsy Treatment
NCT04306952
Feasibility and Efficacy Study of Student Wellness Online Course for Medical Students
NCT03039660
Feasibility of Remote Tai Chi
NCT05693805
Interoceptive Engagement
NCT03583060
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants in the experimental group will receive the information from the intention broadcast for 12 consecutive months, whereas the control condition will receive no treatment for the first 6 months. After the 6-month period, the subjects allocated to the control group will begin to receive treatment in the form of the intention broadcast. To evaluate if treatment gains are sustained past the 12-month intervention period, subjects in the treatment group will provide two follow up assessments at months 15 and 18.
The first six months will enable the investigators to identify any differences in effects between the control and treatment groups. The final six months with the treatment group off the broadcast will enable the study to track the persistence of, or degradation of, any effects. Both groups will have funded 12 months of broadcast, which they will respectively receive, however in a staggered fashion. Participants will not know which group they are in until after the study and will be treated the same throughout.
Random allocation of participants will minimize known and unknown confounding variables between treatment and control group and increase likelihood of one population being studied. Attrition will pose a challenge for this longitudinal design and drop out rate is conservatively estimated to be 25%. The investigators anticipate needing to recruit and enroll approximately 300 subjects in order to attain our goal of 200 - 225 participants with complete data. With 100 subjects in each group, the investigators are expecting to 95% power (2-sided alpha 0.05, effect size d=0.5). The power estimate for this study was based on a prior IHD study by Cindy Reed which was an IRB approved study conducted at Holos University (see references). In that project, of 1784 participants invited to participate in the study nationwide, 452 began the study (took the pre-test) and 303 completed (took the post test), thus an attrition rate of 32%. The investigators anticipate less attrition in this study because of the regular teleconferences that will be offered to both the treatment and control groups.
In addition, to address potential bias, the sub-investigator, Paul Mills, Ph.D., will conduct an analysis comparing the outcomes of those who enter the study but drop out as compared to those who complete the study to gauge potential differences between the two groups, and will report on this potential bias in the published manuscript.
Primary Outcomes. Two primary outcome instruments will be used to determine treatment effects:
1. Self-Compassion Scale - Short Form (12 times). Self-compassion involves being kind toward oneself in times of pain or failure; perceiving one's experiences as part of the larger experience; and holding painful thoughts and feelings in balanced awareness. Questions are rated on a Likert scale from 1 (almost never) to 5 (almost always) with the total score derived by adding the means of each subscale together. The 6 subscales measure an individual's level of self-kindness, self-judgment, common humanity, isolation, mindfulness and over-identification.
2. PROMIS® Global Health Short Form (10 items). The 10 global health items include ratings of the five core PROMIS domains. It includes the most widely used self-rated health item (global01). PROMIS® includes a single item that provides a pure rating of physical health (global03) and another item for mental health (global04). Also included is an overall quality of life item (global02). The remaining items provide global ratings of physical function (global06), fatigue (global08), pain (global07), emotional distress (global10), and social health (global05 and global09). The 10 PROMIS® Global Health items each have 5 response choices, with the exception of the common 11-point pain intensity item ("How would you rate your pain on average" with 0=No pain and 10=Worst imaginable pain).
The treatment group and control group will be analyzed within and across subjects within the Neff Self-Compassion Scale and the PROMIS® Global Health and for emotionally meaningful expressions in their monthly online free-text testimonials. Significant pre- and post differences will be identified using the Linguistic Inquiry and Word Count (2007) text analysis software, with significance analyzed using a set of statistical tests.
Exploratory Outcome. One exploratory outcome instrument will be used to determine treatment effects: Barrett Values Inventory offers additional, exploratory data related to the spiritual growth in the participants. This inventory requires participant's selection of 10 values from a set of 40 values and will be taken every three months. Based on the participant's selections, the inventory quantitatively and qualitatively maps their psychological development across 7 dimensions (surviving, conforming, differentiating, individuating, self-actualizing, integrating, and serving). Based on how the selection of values shifts, the investigators will track the participants' progression. This assessment instrument has been used globally to map the values of individuals, organizations, communities and nations. The measurement and tracking of these outcomes will be facilitated by the Barret Values Centre, overseen by the principal investigator. The Barrett model and tools have not gone through a rigorous scientific validation process, and for this reason the basis of the study will be the two prior outcomes, with this set of outcomes being more exploratory. Because the survey template is not standardized the usual validity tests do not apply. The objective of this study is not to validate the Barrett Value Inventory but rather provide an additional exploratory data for the study.
The primary outcome instruments will be completed by participants in or around January/February of 2016 and at the end of each month thereafter until the end of the study. The exploratory Barrett instrument will be completed quarterly. Participants will be alerted during the last week of each month that forms are due on the 5th of the following month.
In addition to this stated design, the research team is interested in the purported phenomenon of "quantum entanglement" as a process that occurs between people and explains anomalous phenomena such as healing (see references). Included in this theory is the "global, emergent entanglement" phenomenon and the investigators are curious if the investigators can test this idea within the context of the proposed study. Thus, the investigators will add an additional but smaller control group which will complete the same three questionnaires for the first 6 months only and will be unaware of the larger study being conducted. These 50 subjects will be told they as subjects are completing the questionnaires in the context of a distinct, separate study and will be unaware of the Consciousness Field Project.
Outcomes. Four outcome instruments will be used to determine treatment effects:
1. Self-Compassion Scale - Short Form (12 items). Self-compassion involves being kind toward oneself in times of pain or failure; perceiving one's experiences as part of the larger experience; and holding painful thoughts and feelings in balanced awareness. Questions are rated on a Likert scale from 1 (almost never) to 5 (almost always) with the total score derived by adding the means of each subscale together. The 6 subscales measure an individual's level of self-kindness, self-judgment, common humanity, isolation, mindfulness and over-identification.
2. PROMIS® Global Health Short Form (10 items). The 10 global health items include ratings of the five core PROMIS domains. It includes the most widely used self-rated health item (global01). PROMIS® includes a single item that provides a pure rating of physical health (global03) and another item for mental health (global04). Also included is an overall quality of life item (global02). The remaining items provide global ratings of physical function (global06), fatigue (global08), pain (global07), emotional distress (global10), and social health (global05 and global09). The 10 PROMIS® Global Health items each have 5 response choices, with the exception of the common 11-point pain intensity item ("How would you rate your pain on average" with 0=No pain and 10=Worst imaginable pain).
3. Linguistic Inquiry and Word Count (2007) text analysis of emotionally meaningful expressions in participant monthly testimonials.
4. Barrett Values Inventory offers additional, exploratory data related to the spiritual growth in the participants. This inventory requires participant's selection of 10 values from a set of 40 values and will be taken every three months. Based on the participant's selections, the inventory quantitatively and qualitatively maps their psychological development across 7 dimensions (surviving, conforming, differentiating, individuating, self-actualizing, integrating, and serving). Based on how the selection of values shifts, the investigators will track the participants' progression. This assessment instrument was created in 1998 by Richard Barrett \& Associates and has been used globally to map the values of individuals, organizations, communities and nations. The measurement and tracking of these outcomes will be facilitated by the Barret Values Centre, overseen by the principal investigator. The Barrett model and tools have not gone through a rigorous scientific validation process, and for this reason the basis of the study will be the two prior outcomes, with this set of outcomes being more exploratory. Because the survey template is not standardized the usual validity tests do not apply. The objective of this study is not to validate the Barrett Value Inventory but rather provide an additional exploratory data for the study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Wellness Intention Transmission Groups
Aim of this part of the study is to examine whether intention broadcasted from an Intention Host Device (a device which stores and transmits an intention) will affect self-compassion, general wellness, and awakening. 300 trial participants will be randomly allocated to 1/3 in control and 2/3 in the experimental IHD group, respectively. Differences in outcomes between control and experimental groups are expected.
To address potential bias, those who enter the study but drop out are compared to those who complete the study to gauge potential differences between the two groups, and will report on this potential bias in the published manuscript.
Wellness Intention
Independent Control Group
Due to the "global, emergent entanglement" phenomenon, the investigators are curious if the investigators can test this idea within the context of the proposed study. The investigators added an additional but smaller control group which will complete the same three questionnaires for the first 6 months only and will be unaware of the larger study being conducted. These 50 subjects will be told they are completing the questionnaires in the context of a distinct, separate study and will be unaware of the Consciousness Field Project.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Wellness Intention
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, San Diego
OTHER
Merraki Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Gabriele Hilberg, PhD, MFT
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Paul Mills, Ph.D.
Role: STUDY_DIRECTOR
Professor of Family Medicine and Public Health, UC San Diego
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Merraki Institute
Palo Alto, California, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Radin D, Hayssen G, Walsh J. Effects of intentionally enhanced chocolate on mood. Explore (NY). 2007 Sep-Oct;3(5):485-92. doi: 10.1016/j.explore.2007.06.004.
Radin D, Schlitz M, Baur C. Distant Healing Intention Therapies: An Overview of the Scientific Evidence. Glob Adv Health Med. 2015 Nov;4(Suppl):67-71. doi: 10.7453/gahmj.2015.012.suppl. Epub 2015 Nov 1.
Targ E. Evaluating distant healing: a research review. Altern Ther Health Med. 1997 Nov;3(6):74-8.
Nisha Manek, William Tiller. Feasibility of Information Medicine as Delivered by Intention Host Devices: A Case Report Glob Adv Health Med. 2013 Nov; 2(Suppl): S152. Published online 2013 Nov 1. doi: 10.7453/gahmj.2013.097CP.P05.09 PMCID: PMC3875095
Hyland ME. Does a form of 'entanglement' between people explain healing? An examination of hypotheses and methodology. Complement Ther Med. 2004 Dec;12(4):198-208. doi: 10.1016/j.ctim.2004.10.002.
Related Links
Access external resources that provide additional context or updates about the study.
Whitepapers: #1 and # XVI and # XXIV and # XXX and # XXI
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.